{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T14:07:03Z","timestamp":1784210823630,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Polish National Science Center","award":["NN402254634"],"award-info":[{"award-number":["NN402254634"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.cyto.2018.10.024","type":"journal-article","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T17:41:02Z","timestamp":1541180462000},"page":"440-445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The imbalance of peripheral interleukin-18 and transforming growth factor-\u03b21 levels in patients with cirrhosis and esophageal varices"],"prefix":"10.1016","volume":"113","author":[{"given":"Agnieszka","family":"Swidnicka-Siergiejko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urszula","family":"Wereszczynska-Siemiatkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7846-8442","authenticated-orcid":false,"given":"Andrzej","family":"Siemiatkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Wasielica-Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Janica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Mroczko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Dabrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2018.10.024_b0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1155\/2011\/706032","article-title":"Classification of cirrhosis: The clinical use of HVPG measurements","volume":"31","author":"Garcia-Tsao","year":"2011","journal-title":"Dis. Markers."},{"key":"10.1016\/j.cyto.2018.10.024_b0010","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1053\/j.gastro.2008.03.007","article-title":"Portal Hypertension and its complications","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2018.10.024_b0015","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/j.jhep.2008.01.021","article-title":"The management of portal hypertension: rational basis, available treatments and future options","volume":"48","author":"Bosch","year":"2008","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cyto.2018.10.024_b0020","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/j.jhep.2015.01.003","article-title":"Evolution in the understanding of the pathophysiological basis of portal hypertension: how changes in paradigm are leading to successful new treatments","volume":"62","author":"Bosch","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cyto.2018.10.024_b0025","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cyto.2015.05.025","article-title":"Endothelin 1 and transforming growth factor-\u03b21 correlate with liver function and portal pressure in cirrhotic patients","volume":"76","author":"Wereszczynka-Siemiatkowska","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2018.10.024_b0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jhep.2014.03.014","article-title":"Inflammation and portal hypertension - the undiscovered country","volume":"61","author":"Mehta","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cyto.2018.10.024_b0035","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cyto.2018.10.024_b0040","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.3748\/wjg.v20.i10.2564","article-title":"Immune dysfunction in cirrhosis","volume":"20","author":"Sipeki","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cyto.2018.10.024_b0045","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.4254\/wjh.v7.i16.1974","article-title":"Role of systemic inflammation in cirrhosis: From pathogenesis to prognosis","volume":"7","author":"Dirchwolf","year":"2015","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.cyto.2018.10.024_b0050","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3748\/wjg.v21.i41.11522","article-title":"Inflammatory status in human hepatic cirrhosis","volume":"21","author":"Mart\u00ednez-Esparza","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cyto.2018.10.024_b0055","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.3390\/biom5032023","article-title":"Alcoholic liver disease: role of cytokines","volume":"5","author":"Neuman","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.cyto.2018.10.024_b0060","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.3389\/fimmu.2017.01728","article-title":"Relevance of the NLRP3 inflammasome in the pathogenesis of chronic liver disease","volume":"8","author":"Wu","year":"2017","journal-title":"Front Immunol."},{"key":"10.1016\/j.cyto.2018.10.024_b0065","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1478-3231.2004.0967.x","article-title":"Circulating concentrations of interleukin-18, interleukin-18 binding protein, and gamma interferon in patients with alcoholic hepatitis","volume":"24","author":"Spahr","year":"2004","journal-title":"Liver Int."},{"key":"10.1016\/j.cyto.2018.10.024_b0070","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1023\/A:1020600230977","article-title":"Plasma levels of interleukin-18 and interleukin-18 binding protein are elevated in patients with chronic liver disease","volume":"22","author":"Ludwiczek","year":"2002","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.cyto.2018.10.024_b0075","doi-asserted-by":"crossref","first-page":"e514","DOI":"10.1111\/j.1365-2567.2008.03021.x","article-title":"Elevation of interleukin-18 in chronic hepatitis C: implications for hepatitis C virus pathogenesis","volume":"128","author":"Sharma","year":"2009","journal-title":"Immunology."},{"key":"10.1016\/j.cyto.2018.10.024_b0080","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1080\/003655202320378310","article-title":"Serum profiles of interleukin-18 in different severity forms of human acute pancreatitis","volume":"37","author":"Wereszczynska-Siemiatkowska","year":"2002","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.cyto.2018.10.024_b0085","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1089\/jir.2011.0050","article-title":"Interleukin-18: a mediator of inflammation and angiogenesis in rheumatoid arthritis","volume":"31","author":"Volin","year":"2011","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.cyto.2018.10.024_b0090","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3389\/fimmu.2013.00289","article-title":"Interleukin-18 and IL-18 binding protein","volume":"4","author":"Dinarello","year":"2013","journal-title":"Front Immunol."},{"key":"10.1016\/j.cyto.2018.10.024_b0095","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1034\/j.1600-0528.2002.017418.x","article-title":"Pathophysiological roles of interleukin-18 in inflammatory liver diseases","volume":"174","author":"Tsutsui","year":"2000","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cyto.2018.10.024_b0100","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/hep.21907","article-title":"Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Practice guidelines committee of the American association for the study of liver diseases; practice parameters committee of the American college of gastroenterology","volume":"46","author":"Garcia-Tsao","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2018.10.024_b0105","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/hep.21563","article-title":"Advanced liver disease study group, the model for end-stage liver disease (MELD)","volume":"45","author":"Kamath","year":"2007","journal-title":"Hepatology."},{"key":"10.1016\/j.cyto.2018.10.024_b0110","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/hep.22934","article-title":"The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesis","volume":"50","author":"Weng","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2018.10.024_b0115","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.trsl.2008.11.008","article-title":"Interleukin-18 promoter polymorphisms and the disease progression of Hepatitis B virus-related liver disease","volume":"153","author":"Migita","year":"2009","journal-title":"Transl. Res."},{"key":"10.1016\/j.cyto.2018.10.024_b0120","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.24552","article-title":"Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice","volume":"54","author":"Li","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2018.10.024_b0125","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jhep.2011.11.013","article-title":"Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice","volume":"65","author":"Zhu","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cyto.2018.10.024_b0130","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1189\/jlb.0604332","article-title":"Development and functional consequences of LPS tolerance in sinusoidal endothelial cells of the liver","volume":"77","author":"Uhrig","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cyto.2018.10.024_b0135","doi-asserted-by":"crossref","first-page":"d793","DOI":"10.2741\/A812","article-title":"Roles of TGF-beta in hepatic fibrosis","volume":"7","author":"Gressner","year":"2002","journal-title":"Front Biosci."},{"key":"10.1016\/j.cyto.2018.10.024_b0140","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1111\/febs.13665","article-title":"IT-LIVER Consortium, TGF-\u03b2 signalling and liver disease","volume":"283","author":"Fabregat","year":"2016","journal-title":"FEBS. J."},{"key":"10.1016\/j.cyto.2018.10.024_b0145","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/jb\/mvq043","article-title":"Cellular and molecular basis for the regulation of inflammation by TGF-beta","volume":"147","author":"Yoshimura","year":"2010","journal-title":"J. Biochem."},{"key":"10.1016\/j.cyto.2018.10.024_b0150","doi-asserted-by":"crossref","first-page":"12284","DOI":"10.1128\/JVI.01962-13","article-title":"Hepatitis C virus induces interleukin-1\u03b2 (IL-1\u03b2)\/IL-18 in circulatory and resident liver macrophages","volume":"87","author":"Shrivastava","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2018.10.024_b0155","first-page":"161","article-title":"Effects of interleukin-18 and anti-interleukin-18-mAb on experimental immunological liver fibrosis induced by repeatedly administrated concavalian A and its mechanism","volume":"3","author":"Tan","year":"2014","journal-title":"Inf. Int. (Electronic Edition)"},{"key":"10.1016\/j.cyto.2018.10.024_b0160","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1007\/BF03402053","article-title":"Lack of interferon-gamma production despite the presence of interleukin-18 during cutaneous wound healing","volume":"6","author":"K\u00e4mpfer","year":"2000","journal-title":"Mol. Med."},{"key":"10.1016\/j.cyto.2018.10.024_b0165","doi-asserted-by":"crossref","first-page":"40391","DOI":"10.1074\/jbc.M112.402420","article-title":"Profibrotic effect of interleukin-18 in HK-2 cells is dependent on stimulation of the Toll-like receptor 4 (TLR4) promoter and increased TLR4 expression","volume":"287","author":"Meldrum","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2018.10.024_b0170","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.4049\/jimmunol.159.8.3961","article-title":"IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice","volume":"159","author":"Tsutsui","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2018.10.024_b0175","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1084\/jem.20011022","article-title":"Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis","volume":"195","author":"Gerdes","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2018.10.024_b0180","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1136\/ard.2009.127241","article-title":"Interleukin 18 induces angiogenesis in vitro and in vivo via Src and Jnk kinases","volume":"69","author":"Amin","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2018.10.024_b0185","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.4049\/jimmunol.167.3.1644","article-title":"Evidence of IL-18 as a novel angiogenic mediator","volume":"167","author":"Park","year":"2001","journal-title":"J. Immunol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466618304113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466618304113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T18:29:18Z","timestamp":1694024958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466618304113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":37,"alternative-id":["S1043466618304113"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2018.10.024","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The imbalance of peripheral interleukin-18 and transforming growth factor-\u03b21 levels in patients with cirrhosis and esophageal varices","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2018.10.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}